N-Methyl diethanolamine (MDEA) is an economical organic amine compound used for natural gas sweetening and carbon dioxide capture. It is soluble in hydrocarbons, chemically stable, non-toxic and cost-effective compared to other amines. MDEA efficiently removes acid gases like hydrogen sulfide and carbon dioxide via chemisorption and is regenerable by heat treatment. The recovered MDEA can be recycled and reused for further absorption. With rising demand for energy, natural gas processing has increased significantly leading to higher consumption of MDEA in facilities for acid gas removal.
The Global N-Methyl Diethanolamine (MDEA) Market is estimated to be valued at US$ 91.91 Bn in 2024 and is expected to exhibit a CAGR of 9.3% over the forecast period of 2024 to 2030.
Key Takeaways
Key players operating in the N-Methyl Diethanolamine (MDEA) are GlaxoSmithKline plc, Novartis AG, Pfizer Inc., AstraZeneca plc, Boehringer Ingelheim International GmbH, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Bayer AG, Sanofi S.A., Sunovion Pharmaceuticals Inc., Mylan N.V., Cipla Ltd., Grifols S.A., Insmed Incorporated, Arbor Pharmaceuticals LLC. Key players are focusing on capacity expansion plans to meet the growing demand for MDEA.
The growing demand for natural gas led to an increase in extraction and processing activities. This has resulted in increased consumption of MDEA used for removing acid gases in gas sweetening plants. Furthermore, policies supporting carbon capture and storage are further expected to drive the MDEA market.
Asia Pacific dominates the global MDEA capacity, with China being the major producer as well as consumer. However, North America and Europe are also projected to witness healthy growth in demand for MDEA in the coming years due to robust natural gas production in countries like the US. Meanwhile, the Middle East & Africa are emerging as new hotspots for gas exploration and LNG trade, thereby powering MDEA adoption.
Market Key Trends
One of the key trends in the MDEA Market Demand is the development of hybrid amines and advanced solvents for low-temperature acid gas removal. As MDEA usage may induce corrosion at lower temperatures, integrating other amines like tertiary amines is being researched upon. This helps widen the operational window for robust gas treatment. Similarly, manufacturers are formulating proprietary MDEA mixtures and multi-amine blends to achieve overall process efficiency and cost optimization. Such product innovations will continue shaping the future market landscape for MDEA.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate as the capital requirement to set up manufacturing facilities for MDEA is high. Bargaining power of buyers: The bargaining power of buyers is moderate as MDEA has applications in end-use industries like gas treatment and others. Bargaining power of suppliers: The bargaining power of suppliers is moderate as raw materials for MDEA production are easily available. Threat of new substitutes: The threat of new substitutes is low as there are limited substitutes available for MDEA. Competitive rivalry: Competition in the MDEA market is moderate to high.
Geographical Regions
The North America region accounts for the largest share of the global MDEA market in terms of value due to rising demand for gas treatment processes in end-use industries.
The Asia Pacific region is expected to witness the fastest growth in the MDEA market during the forecast period. Increasing natural gas production and rising demand for gas treating applications from countries like China and India are fueling market growth.